ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.94439
0.00%
Brent Oil
83.785
0.29%
Bitcoin
57,454.94
-1.34%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Pacific Biosciences of California Inc (PACB)

  7. Pacific Biosciences of California Inc (PACB) Noticias

PACB Pacific Biosciences of California Inc

1.75
0.10 (6.06%)
01 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Pacific Biosciences of California Inc PACB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.10 6.06% 1.75 18:10:26
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.66 1.58 1.83 1.69 1.65
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/4/202407:05PRNUSPacBio Announces Preliminary First Quarter 2024 Revenue and..
27/3/202407:00PRNUSEstonia National Biobank Selects PacBio to Sequence 10,000..
22/3/202415:30PRNUSPacBio Grants Equity Incentive Award to New Employee
12/3/202408:05PRNUSPacBio Announces PureTarget™ Repeat Expansion Panel,..
06/3/202416:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202417:32EDGAR2Form 144 - Report of proposed sale of securities
04/3/202417:22EDGAR2Form 144 - Report of proposed sale of securities
26/2/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202415:05PRNUSPacBio to Present at Upcoming Investor Conferences
21/2/202417:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202417:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202417:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202415:17EDGAR2Form 144 - Report of proposed sale of securities
16/2/202416:54EDGAR2Form 144 - Report of proposed sale of securities
16/2/202416:52EDGAR2Form 144 - Report of proposed sale of securities
16/2/202416:06EDGAR2Form 144 - Report of proposed sale of securities
15/2/202415:07EDGAR2Form 8-K - Current report
15/2/202415:05PRNUSPacBio Announces Fourth Quarter and Fiscal Year 2023..
13/2/202415:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202406:00PRNUSExperiential Marketing Firm VOLO Events Agency Wins Best..
12/2/202416:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202405:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202408:05PRNUSPacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96..
05/2/202405:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202415:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202415:03PRNUSPacBio to Report Fourth Quarter 2023 Financial Results on..
24/1/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/1/202408:05PRNUSPacBio Announces New Nanobind PanDNA Kit Enabling HiFi..
10/1/202416:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202415:26EDGAR2Form 144 - Report of proposed sale of securities
08/1/202407:03EDGAR2Form 8-K - Current report
08/1/202407:00PRNUSPacBio Announces Record Preliminary Fourth Quarter and Full..
27/12/202315:05PRNUSPacBio to Present at 42nd Annual J.P. Morgan Healthcare..
11/12/202307:06EDGAR2Form 8-K - Current report
11/12/202307:00PRNUSPacBio Announces the Retirement of David Botstein, Ph.D.,..
09/11/202315:10PRNUSPacBio to Present at Upcoming Investor Conferences
03/11/202315:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202308:05PRNUSPacBio Announces HiFi Solves, a Global Consortium of..
01/11/202308:05PRNUSPacBio Enables Rare and Inherited Disease Research by Adding..
31/10/202308:05PRNUSPacBio Announces Kinnex RNA Kits, Further Scaling HiFi..
30/10/202315:06EDGAR2Form 8-K - Current report
30/10/202315:03PRNUSPacBio Announces Third Quarter 2023 Financial Results
27/10/202316:00EDGAR2Form 8-K/A - Current report: [Amend]

Su Consulta Reciente

NASDAQ
PACB
Pacific Biosciences of C...
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados